TY - JOUR
T1 - An update on iron homeostasis
T2 - Make new friends, but keep the old
AU - Roy, Cindy N.
N1 - Funding Information:
Supported by the Southern Society of Clinical Investigation.
PY - 2013/11
Y1 - 2013/11
N2 - A classic Girl Scout song says, "Make new friends/but keep the old/One is silver/and the other gold." This review focuses on the past decade of discovery in the field of iron homeostasis, which has identified "new friends" or key modifiers of the critical systemic iron regulator, hepcidin antimicrobial peptide. The foundation for these discoveries has been the identification of mutated genes in well-characterized cohorts of patients with inherited hemochromatosis from across the globe. Transgenic mouse models of iron overload and iron-restricted anemia have also contributed to understanding molecular pathophysiology in ways that could never be accomplished in human subjects alone. The majority of these newly discovered molecules coordinate signaling through the bone morphogenetic protein pathway of ligands, receptors and coreceptors, intracellular signaling and transcription. The discovery of these proteins and their interactions with "old friends," such as the 1st known hereditary hemochromatosis gene product, HFE and transferrin receptor, has opened the field of iron homeostasis to include regulatory networks involving signal transduction pathways, in particular, the mitogen-activated protein kinase and Smad pathways. These newly discovered partnerships have also made way for opportunities to develop novel therapeutics for the treatment of iron regulatory disorders, including hemochromatosis.
AB - A classic Girl Scout song says, "Make new friends/but keep the old/One is silver/and the other gold." This review focuses on the past decade of discovery in the field of iron homeostasis, which has identified "new friends" or key modifiers of the critical systemic iron regulator, hepcidin antimicrobial peptide. The foundation for these discoveries has been the identification of mutated genes in well-characterized cohorts of patients with inherited hemochromatosis from across the globe. Transgenic mouse models of iron overload and iron-restricted anemia have also contributed to understanding molecular pathophysiology in ways that could never be accomplished in human subjects alone. The majority of these newly discovered molecules coordinate signaling through the bone morphogenetic protein pathway of ligands, receptors and coreceptors, intracellular signaling and transcription. The discovery of these proteins and their interactions with "old friends," such as the 1st known hereditary hemochromatosis gene product, HFE and transferrin receptor, has opened the field of iron homeostasis to include regulatory networks involving signal transduction pathways, in particular, the mitogen-activated protein kinase and Smad pathways. These newly discovered partnerships have also made way for opportunities to develop novel therapeutics for the treatment of iron regulatory disorders, including hemochromatosis.
KW - Bone morphogenetic protein
KW - Hepcidin
KW - Hereditary hemochromatosis
KW - Iron homeostasis
UR - http://www.scopus.com/inward/record.url?scp=84887252574&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84887252574&partnerID=8YFLogxK
U2 - 10.1097/MAJ.0000000000000190
DO - 10.1097/MAJ.0000000000000190
M3 - Article
C2 - 24157963
AN - SCOPUS:84887252574
SN - 0002-9629
VL - 346
SP - 413
EP - 419
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 5
ER -